GSA Capital Partners LLP Has $1.09 Million Position in Viemed Healthcare, Inc. (NASDAQ:VMD)

Key Points

• GSA Capital Partners LLP significantly increased its stake in Viemed Healthcare, Inc. by 497.7% in the first quarter, acquiring an additional 124,731 shares to own 149,791 shares valued at approximately $1,090,000.
• Other institutional investors also enhanced their positions in Viemed Healthcare, with hedge funds owning 74.24% of the company, highlighting a strong interest from larger financial players.
• Viemed Healthcare reported $0.06 earnings per share for the last quarter, matching expectations, with revenues totaling $59.1 million, slightly below consensus estimates.

GSA Capital Partners LLP raised its stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 497.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 149,791 shares of the company's stock after buying an additional 124,731 shares during the period. GSA Capital Partners LLP owned approximately 0.38% of Viemed Healthcare worth $1,090,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of VMD. Divisadero Street Capital Management LP grew its stake in shares of Viemed Healthcare by 84.8% in the 4th quarter. Divisadero Street Capital Management LP now owns 646,273 shares of the company's stock worth $5,183,000 after purchasing an additional 296,481 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Viemed Healthcare by 2.3% in the 4th quarter. Renaissance Technologies LLC now owns 373,000 shares of the company's stock worth $2,991,000 after purchasing an additional 8,400 shares during the last quarter. Northern Trust Corp grew its stake in shares of Viemed Healthcare by 1.8% in the 4th quarter. Northern Trust Corp now owns 286,818 shares of the company's stock worth $2,300,000 after purchasing an additional 5,090 shares during the last quarter. Apis Capital Advisors LLC grew its stake in shares of Viemed Healthcare by 14.4% in the 4th quarter. Apis Capital Advisors LLC now owns 279,600 shares of the company's stock worth $2,242,000 after purchasing an additional 35,200 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of Viemed Healthcare by 131.4% in the 4th quarter. JPMorgan Chase & Co. now owns 228,652 shares of the company's stock worth $1,834,000 after purchasing an additional 129,854 shares during the last quarter. Institutional investors and hedge funds own 74.24% of the company's stock.

Insider Activity at Viemed Healthcare

In other Viemed Healthcare news, Director Nitin Kaushal sold 34,100 shares of the firm's stock in a transaction dated Friday, June 27th. The shares were sold at an average price of $7.01, for a total value of $239,041.00. Following the completion of the transaction, the director directly owned 126,843 shares in the company, valued at $889,169.43. This trade represents a 21.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 20.00% of the stock is currently owned by insiders.

Viemed Healthcare Price Performance

Shares of VMD traded down $0.16 during mid-day trading on Friday, hitting $5.93. The company's stock had a trading volume of 296,959 shares, compared to its average volume of 220,438. The firm has a 50-day moving average price of $6.67 and a 200 day moving average price of $7.14. The stock has a market capitalization of $234.35 million, a price-to-earnings ratio of 19.77 and a beta of 1.34. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.38 and a quick ratio of 1.26. Viemed Healthcare, Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $9.81.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. Viemed Healthcare had a net margin of 5.28% and a return on equity of 9.49%. The company had revenue of $59.10 million during the quarter, compared to analysts' expectations of $60.60 million.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.